Evidence has shown that adiponectin, an adipocyte-secreted adipokine involved in the control of basal metabolism is markedly reduced in T2DM [41], which favors the deregulation in glucose and insulin metabolism [42]. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.